Covered recipient · General Payments record
RONNIE-JANE BOEKEMA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,514.03
- Reported across 195 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $213.13 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $88.41 | 4 |
| GlaxoSmithKline, LLC. | $36.68 | 2 |
| Teva Pharmaceuticals USA, Inc. | $35.11 | 2 |
| Acerta Pharma LLC | $24.07 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.82 | 1 |
| Exact Sciences Corporation | $14.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.79 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106785496 | CMS |
| ABBVIE INC. | $16.88 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106785500 | CMS |
| ABBVIE INC. | $28.93 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106785504 | CMS |
| ABBVIE INC. | $20.81 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106785507 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.07 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104304130 | CMS |
| Exact Sciences Corporation | $14.04 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114594943 | CMS |
| GlaxoSmithKline, LLC. | $16.44 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116689857 | CMS |
| GlaxoSmithKline, LLC. | $20.24 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116571259 | CMS |
| Novartis Pharmaceuticals Corporation | $14.82 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086765081 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.14 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151609870 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.97 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151609872 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.